BBIO
BridgeBio Pharma Inc.
Company Overview
| Mkt Cap | $12.33B | Price | $62.64 |
| Volume | 2.47M | Change | -1.15% |
| P/E Ratio | -23.0 | Open | $63.88 |
| Revenue | $221.9M | Prev Close | $63.37 |
| Net Income | $-535.8M | 52W Range | $21.72 - $69.48 |
| Div Yield | N/A | Target | $67.70 |
| Overall | 65 | Value | 40 |
| Quality | -- | Technical | 90 |
No chart data available
Stock Overview
Updated DailyBridgeBio Pharma Inc. (BBIO) is a leading Manufacturing company in the Pharmaceutical Preparation Manufacturing industry, currently trading at $62.64 with a market capitalization of $12.33 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows BBIO with a volume of 2.47 million shares. The stock opened up 0.80% from yesterday's close of $63.37. Current analyst estimates project earnings of $-3.47 per share for this year, with next year targeting $-2.01.
BBIO demonstrates very strong technical momentum based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including OMHE, OILS-CA, OGN, ONPH.
Key investment considerations for BBIO include solid overall investment characteristics. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 8.1%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 04:41 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BBIO | $62.64 | -1.2% | 2.47M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |